Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Zydus Lifesciences, Sterling Biotech and API
Zydus Lifesciences To Acquire Sterling Biotech's Active Pharmaceutical Ingredients Business
Zydus Lifesciences is one of the biggest names in the pharma business of the country. In a recent development, the company has announced of a crucial acquisition deal. The company announced the 50 per cent acquisition of Mumbai-based Sterling Biotech Ltd.
Zydus Lifesciences to acquire Sterling Biotech's API biz for Rs 84 crore
Zydus Lifesciences Ltd on Tuesday said it will acquire the 'Target Business' of Sterling Biotech primarily engaged in manufacturing of fermentation-based active pharmaceutical ingredients products and a production facility at Masa in Gujarat for a pre-agreed sum of Rs 84 crore.
Zydus Lifesciences Acquires Sterling Biotech's API Business for ₹84 Crore
Zydus Lifesciences shares faced selling pressure during the September 17 trading session following the board’s approval to acquire the API business of Sterling Biotech for ₹84 crore. The acquisition announcement follows the company’s earlier decision to buy a 50% stake in Sterling Biotech.
Zydus Lifesciences Shares Close In Red After Announcing Acquisition Of Sterling Biotech's API Business
Zydus Lifesciences shares closed in red on Tuesday, September 16. This came to pass after the company announced the acquisition of Sterling Biotech Ltd's API or Active Pharmaceutical Ingredients Business.
Zydus Lifesciences board approves acquisition of API business of Sterling Biotech for Rs 84 crore
Sterling Biotech is one of the large manufacturers of pharmaceutical gelatin, di-calcium phosphate and APIs including lovastatin, doxorubicin, epirubicin, and daunorubicin
Zydus Lifesciences to acquire Sterling Biotech's API business for ₹84 crore
In August this year when Zydus acquired a 50% stake in Sterling Biotech Ltd (SBL), the company negotiated for the right to acquire the 'Target Business' of SBL at a pre-defined value.
Zydus Lifesciences To Acquire Sterling Biotech's Fermentation-Based API Business for Rs 84 Crore
In August this year when Zydus acquired a 50% stake in Sterling Biotech Ltd., the company negotiated for the right to acquire the 'Target Business' of SBL at a pre-defined value.
17h
Zydus Wellness subsidiary faces ₹10.51 million tax demand in Bihar, stock slips
Zydus Wellness Limited announced today that its wholly-owned subsidiary, Zydus Wellness Products Limited (ZWPL), has received ...
FiercePharma
7d
India's Zydus hit with warning letter as FDA flags glass contamination concerns and more
Last week, Zydus Lifesciences confirmed the receipt of an FDA warning letter at its Waghodia plant in Gujarat, India, marking ...
1d
on MSN
Zydus Lifesciences pulled up by USFDA for manufacturing lapses at Gujarat plant
Zydus Lifesciences has been pulled up by the US health regulator for manufacturing lapses at its Gujarat-based plant.In a ...
2d
Zydus Life shares gain on signing licensing & supply agreement with US-based company
Zydus Lifesciences has secured an exclusive licensing and supply agreement with the US-based Viwit Pharmaceuticals for two ...
cnbctv18
5d
Zydus Life arm signs exclusive US licensing and supply pact for MRI contrast agents
Zydus' agreement with Viwit Pharmaceuticals covers the supply of gadobutrol and gadoterate meglumine injections, widely used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Food and Drug Administration
Target Business
Gujarat
Magnetic resonance imaging
USFDA
Feedback